Announcements

ASTCT 2022 National Fludarabine Shortage for HCT and CAR-T Cell Recipients: Frequently Asked Questions
October 24, 2022

 

Press Releases

Miguel-Angel Perales, M.D., Named 2023 - 2024 President of ASTCT
February 20, 2023

GVHD Alliance to Honor Steven Pavletic With the Inaugural Lukas D. Wartman GVHD Achievement Award
February 16, 2023

ASTCT to Present Distinguished Honors at the 2023 Tandem Meetings
January 17, 2023

The Global Community of Hematopoietic Cell Transplantation and Cellular Therapy Specialists Will Gather for the 2023 Tandem Meetings
November 30, 2022

The AcCELLerate Forum to Focus on Creating a Sustainable Ecosystem of Cell and Gene Therapy
October 24, 2022

Dr. Owhofasa Agbedia to Receive the 2021 ASH-CIBMTR-ASTCT Career Development Award
June 22, 2022

ASTCT Gives Distinguished Honors at the 2022 Tandem Meetings
April 27, 2022

Brenda M. Sandmaier, M.D., Named ASTCT 2022-2023 President
April 26, 2022

 

Advocacy Statements

Joint Statements
2022 - Joint ASTCT, EBMT, WBMT Statement Regarding Ukraine

IPPS Prospective Payment System (IPPS)
2021 - FY 2022 IPPS Proposed Rule Comment Letter

Outpatient Prospective Payment System (OPPS) and Hospital Outpatient Panel (HOP) Presentations
2021 - CY 2022 OPPS Proposed Rule Comment Letter

CPT/HCPCS/ICD-10 Coding Advocacy
2021 - ICD-10-PCS Procedure Comment Letter

 
Other Letters

2022 – ASTCT, AHS, NMDP/Be the Match joint letter to CDC COVID-19 Response Team

2021 - ASTCT, CIBMTR, NMDP/Be the Match Joint Revaccination Letter to CDC

2021 - Palliative Care Act Letter of Support

2021 - Vaccine Allocation Letter to CDC

 

For press inquiries, contact Jennifer Kasowicz, Director of Marketing, jkasowicz@astct.org. 

For advocacy or GR inquiries, contact Alycia Maloney, Director of Government Relations, amaloney@astct.org.